| Catasys (NASDAQ: CATS) Expands OnTrak-A Solution in California with Leading National Health Plan |
| |
|
Catasys (NASDAQ: CATS), a leading AI and technology-enabled healthcare company, today announced the expansion of its OnTrak-A solution with a leading national health plan into California beginning January 31, 2020. This expansion ensures that eligible commercial members of the health plan in California will have access to critical behavioral healthcare to help them better manage chronic disease. This is the first of several planned OnTrak-A expansions in 2020.
Why It Matters: OnTrak is a critical component of the Catasys PRETM (Predict-Recommend-Engage) platform that predicts people whose chronic disease will improve with behavior change, recommends care pathways that are effective and that people will follow, and engages people who aren’t getting the care they need. OnTrak is an integrated solution that incorporates evidence-based psychosocial and medical interventions delivered either in-person or via telehealth, along with care coaching and in-market Community Care Coordinators who address the social and environmental determinants of health. OnTrak improves member health and delivers validated cost savings of more than 50% for enrolled members.
Key Quote: “As we continue to see the significant toll that unaddressed behavioral health conditions take on people with chronic disease, it’s paramount that we reach, engage and treat as many members as possible. That is why we are particularly thrilled to be significantly increasing our outreach pool of eligible members through this expansion, further strengthening our partnership with this plan and their employer partners. This is a testament to the improved health outcomes that OnTrak yields." – Terren Peizer, Chairman & CEO
The Backstory: Catasys is a leading AI and technology-enabled healthcare company whose mission is to help improve the health and save the lives of as many people as possible. Its Catasys PRETM (Predict-Recommend-Engage) platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages people who aren’t getting the care they need. By combining predictive analytics with human engagement, Catasys delivers improved member health and validated outcomes and savings to healthcare payers.
Disclosure
Catasys (CATS) is a client of RedChip Companies, Inc. CATS agreed to pay RedChip Companies, Inc. a $5,000 monthly cash fee, beginning in February 2017, for RedChip investor awareness services and consulting services.
|
|
| |
|
| Nemaura (NASDAQ: NMRD) Provides 2019 Year-End Corporate Update |
| |
|
Nemaura Medical (NASDAQ: NMRD) a medical technology company commercializing sugarBEAT®, a non-invasive and flexible continuous glucose monitor (CGM), together with BEAT®diabetes, a health subscription service designed to help people with diabetes and prediabetes to better manage their condition through personalized lifestyle coaching, provided a 2019 year-end corporate update.
- Began first phase of commercial launch of sugarBEAT
- Launched digital health offering, BEAT®diabetes
- Announced partnership with award-winning UK-based Changing Health
- Adequate cash on hand and secured $8 million debt facility
- Regained NASDAQ compliance
Key Quote: “2019 was a transformative year for our Company as we achieved a number of major milestones. During the year, we received CE Mark approval and laid the foundation for the commercial launch of sugarBEAT® in Europe and several other key territories around the world where CE approval can be used as the basis of product registration. We also launched a subscription-based package, BEAT®diabetes to complement sugarBEAT® CGM and provide users with additional digital and non-digital services for the management, reversal or prevention of diabetes.” – Dr. Faz Chowdhurry, CEO
The Backstory: Nemaura’s sugarBEAT® is a non-invasive and flexible continuous glucose monitor (CGM) providing actionable insights derived from real time glucose measurements and daily glucose trend data, which help insulin users, type 2 diabetics and pre-diabetics respectively to better manage, reverse and prevent the onset of diabetes. BEAT®diabetes is a health subscription service providing 1-on-1 lifestyle coaching and behavior change recommendations driven by personalized data provided by sugarBEAT®. Insulin users can also adjunctively use sugarBEAT® for insulin dosage purposes when calibrated by a finger stick reading.
Disclosure
Nemaura Medical (NMRD) is a client of RedChip Companies. NMRD agreed to pay RedChip a monthly cash fee of $5,000 for six months of investor awareness services. RedChip also received 20,000 shares of Rule 144 stock for services performed between December 2018 and May 2019.
|
|
| |
|
| SinglePoint (OCTQB: SING) Receives Phenomenal Response to 1606 Original Hemp Cigarettes at 2019 MJ Business Conference |
| |
|
SinglePoint (OTCQB: SING) successfully launched its 1606 Original Hemp cigarettes at the 2019 MJ Business Conference in Las Vegas. The company received its first major purchase order for approximately 5,000 packs of hemp cigarettes from one distributor and expects many more to come over the coming months. The show was attended by approximately 35,000 people this year.
Why It Matters: According to a June 2019 market research report published by MarketsandMarkets™, the industrial hemp market is projected to grow from $4.6 billion in 2019 to $26.6 billion by 2025, recording a compound annual growth rate of 34.0% during the forecast period. The cannabidiol (CBD) market is on track to grow to $23.7 billion through 2023, according to Brightfield Group. The firm also estimated the smokable hemp market to be valued at $11.5 million in 2018, a growth of 250% from 2017.
Key Quote: “The reception for 1606 at MJBIZCON exceeded our expectations. The most surprising to us was just the number of individuals that were truly excited about this product and had never seen anything like it before. As well as the number of people that came back days two and three to tell us how much they enjoyed the product. We know we have a great product here and are ahead of the market. We now need to follow up and sell and establish our brand as the premier brand in the market. I believe we have the head start and quality product to do just that, our first distributor has put in their purchase order for around 5000 packs and we look forward to additional orders from stores and additional distributors.” – Wil Ralston, President
The Backstory: SING invests in and acquires brands and companies that will benefit from injection of growth capital and the sales and marketing expertise of SING. The company portfolio currently includes solar renewables, Hemp and distribution tobacco products. SING is working to grow the company to a multi-national brand
Disclosure
SinglePoint, Inc. (SING) is a client of RedChip Companies, Inc. SING agreed to pay RedChip Companies, Inc. a $10,000 monthly cash fee, beginning in June 2019, for RedChip investor awareness services and consulting services.
|
|
| |
|
| Santa Fe Gold (OTC: SFEG) to Deliver 1500 Tons of Gold and Silver Siliceous Vein Material to Smelter |
| |
|
Santa Fe Gold (OTC: SFEG), a U.S. based mining company that currently ranks 9th out of the top ten US based mid-tier and junior precious metals companies (as cited by mining industry trade journal, The Northern Miner) with 148 mining claims covering 42 mine sites and potential mines, plans to deliver economic grade, high silica gold and silver siliceous vein material from its Jim Crow mine to a smelter under a provisional arrangement to begin deliveries in 2019.
Why It Matters: Management’s goal is to build up production of gold and silver siliceous vein material from its Jim Crow Mine to a targeted production of an aggregate 500 tons per day from multiple mines in time. As higher output of gold and silver siliceous vein material production is achieved from the Jim Crow Mine, the company plans to commence the exploitation and development of the adjacent Imperial Mine and also the Billali Mine.
Key Quote: “This first shipment is a prelude to what we expect to be regular shipments over the first four months of 2020, with the goal of increasing the shipment amounts to 2,000 tons per month if and as capacity increases. Payment is expected to be within 30 days of shipment.” – Brian Adair, Chairman
The Backstory: Santa Fe Gold is a US-based mining and exploration enterprise with 148 mining claims comprising 42 potential mines of which Jim Crow Gold and Silver Mine is already in production. Jim Crow is the first of 11 potential mines in the mining rich Steeple Rock Billali district, with additional mines expected to be brought into production soon. Santa Fe’s goal is to produce near term cash flows from its numerous mine sites, while creating a portfolio of high-quality exploration and bankable development projects, to ensure future revenue growth.
Disclosure
Santa Fe Gold Corp. (SFEG) is a client of RedChip Companies, Inc. SFEG agreed to pay RedChip Companies, Inc. 1,000,000 shares of Rule 144 stock for 12 months of RedChip investor awareness services and consulting services.
|
|
| |
|
| |
| Quote of the Week |
| |
"Higher returns, of course, come with more risk...the trade off is, yes, you get long-term outperformance ... but the volatility of returns is greater... That's the price you pay if you want exposure to a better-performing asset class."
- Samuel Dedio, Manager of the Artio U.S. Microcap Fund (JMCAX) |
|
|
|
|
|
|
|
